Thermo Fisher Scientific (TMO) Operating Margin (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Operating Margin for 18 consecutive years, with 17.4% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Margin rose 50.0% year-over-year to 17.4%; the trailing twelve-month figure through Jun 2026 stood at 17.58% (up 45.0% YoY), and the FY2025 full-year result was 17.38%, up 27.0% from the prior year.
• Operating Margin rose to 17.4% in Q2 2026 per TMO's latest filing, from 16.93% in the prior quarter.
• Across five years, Operating Margin topped out at 23.87% in Q2 2022 and bottomed at 14.59% in Q2 2023.
• Historically, Operating Margin has averaged 17.25% across 5 years, with a median of 17.15% in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Margin plunged 928 bps in 2023, then surged 250 bps in 2024.
• Over 5 years, Operating Margin stood at 16.25% in 2022, then increased by 5 bps to 17.03% in 2023, then grew by 4 bps to 17.69% in 2024, then rose by 4 bps to 18.46% in 2025, then fell by 6 bps to 17.4% in 2026.
• According to Business Quant data, Operating Margin over the past three periods registered 17.4%, 16.93%, and 18.46% for Q2 2026, Q1 2026, and Q4 2025 respectively.